Alibaba Drops 10% Since November: The Race to Buy the Dip

Alibaba: 10% drop since November, no consensus on the bottom

An investor holds 20% of their portfolio in a single stock, averaging 223 euros, with no stop-loss and a five-to-six-year horizon. This is the stake in Alibaba, the Chinese tech giant that has seen, according to market references, nearly a 10% drop since November. The initial warning, delivered with a mix of caution and bravado, was that the Chinese government had intervened and a major sell-off was imminent.

Compounding this was a second front: investors holding shares via the US face new American audit requirements. A third, murkier factor involved insiders—so-called "birds"—leaking that the goal was to crash the stock for a cheap buy before pushing it up. Place your bets, the message concluded.

The 24% drop was already priced in

The first flaw in the thesis is chronological. The serious plunge occurred on Thursday the 24th, when US markets were open, while other exchanges where Alibaba trades were closed. Upon reopening, these markets simply adjusted to the price set across the Atlantic. This is standard behavior when a single asset trades in multiple locations: prices tend to equilibrate.

As one explanation patiently notes: if the stock trades simultaneously in New York, Frankfurt, and Hong Kong, the market with the highest volume sets the price, and others align. It is common sense, summarizes one comment, noting that many others failed to grasp this. The recurring conclusion: the announced crash was not a harbinger, but a late reading of an event that had already occurred.

What you buy when you buy Alibaba

Here lies the warning most relevant to those placing orders without reading the prospectus. The caveat is stark: internationally, you do not buy Alibaba; you buy a company domiciled in the Cayman Islands that holds no ownership stake in Alibaba. A commercial contract allows this vehicle to share in the Chinese company’s profits. The reason? Foreigners cannot directly invest in strategic Chinese enterprises.

This explains the seemingly inconsistent figures. The instrument with the Cayman Islands ISIN trades around 26 euros; the US-listed version is valued at 209 euros after conversion. The latter is considered more exposed to Washington’s regulatory risks.

Is this a buying opportunity below $200?

For some, yes, and they have been saying so for months. Some saw it as cheap even at $300, while others bought on Thursday convinced they had snagged a bargain. The prices cited in discussions reflect a spectrum of low averages: purchases at 212 and 218 euros, averages of 223, sell orders placed at $600, and a medium-term scenario placing the stock at $400. One comment summarizes the sentiment: if it doubles or triples in four years, great; if it goes to zero, no drama.

Against this weighs the stock’s own mechanics. Another school of thought expects to see it below $190 at the session close and prefers to wait for a confirmed rebound. The underlying argument is familiar: markets move on geopolitics and large fund activity, not fundamentals, and timing such interventions is guesswork.

The risk is political, not business-related

This is the conclusion repeated by those who backed the thesis from the start: the company is good and cheap, but everything happening to it is political. Its accounts are irrelevant. In China, one person holds power: Xi Jinping, as several comments emphasize, highlighting the control of the Communist Party of China over the economy. The counterargument points to US interventionism, audits, and blacklists as equally arbitrary, noting that paper liberalism is applied only when convenient.

Comparisons with Amazon appear in the discussion, and Alibaba does not fare well: the US tech giant trades with high expectation premiums; the Chinese one does not even reflect its own fundamentals. The response is a blunt fact: the Chinese market is generally weak, and this is not debated.

Michael Burry and large positions

One cited signal is the portfolio movement of Michael Burry, who holds Alibaba and JD as his top two positions and has completely exited semiconductor options. That a manager known for betting against the US housing bubble is loading up on Chinese tech is read as confirmation that value exists in this sector.

It is also noted that the company trades in multiple markets without its owners yet activating their "euphoria mode." When they do, warn observers, expect dramatic price swings.

The disorienting data point

Amid all this, the most honest summary comes from a comment offering no analysis: that tomorrow they announce a cure for cancer and the stock still drops 2%. It’s an exaggeration, yes. But it describes a stock where fundamentals have been irrelevant for months, and where the only thing moving the price is what Beijing and Washington decide. Nearly a 10% drop since November, with no one able to say if the floor is at 190, 117, or the next headline.